Publications by authors named "Maria I Carlo"

35Publications

The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing.

Cancer Treat Res Commun 2020 Jan 7;23:100165. Epub 2020 Jan 7.

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States. Electronic address:

View Article and Find Full Text PDF
January 2020

CHEK2 Alleles Predispose to Renal Cancer in Poland-In Reply.

JAMA Oncol 2019 04;5(4):576-577

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article and Find Full Text PDF
April 2019

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

J Clin Oncol 2018 06 28;36(17):1685-1694. Epub 2018 Feb 28.

Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley M. Regazzi, Brooke E. Kania, Meredith M. Moran, Catharine K. Cipolla, Mark J. Bluth, Joshua Chaim, Alexandra Snyder, Maria I. Carlo, Michael F. Berger, Samuel Funt, Jedd D. Wolchok, Margaret K. Callahan, and Jonathan E. Rosenberg, Memorial Sloan Kettering Cancer Center; and Hikmat Al-Ahmadie, David B. Solit, Gopa Iyer, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article and Find Full Text PDF
June 2018

Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.

Semin Cell Dev Biol 2017 04 8;64:98-106. Epub 2016 Sep 8.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.

View Article and Find Full Text PDF
April 2017

Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.

Nat Rev Urol 2016 07 21;13(7):420-31. Epub 2016 Jun 21.

Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, New York 10065, USA.

View Article and Find Full Text PDF
July 2016

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis.

Eur Urol 2016 12 13;70(6):1082-1083. Epub 2016 Jun 13.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article and Find Full Text PDF
December 2016